Tubize-Fin(TUB.BR)— 技术面状态
数据截至2026-10-12 — 每个交易日晚间对全部覆盖范围重新计算。Closelook研究日记,不构成投资建议。
Trades -4.6% vs the 50-day and -16.8% vs the 200-day average, 30.6% below the 52-week high and +3% off the 52-week low; a death cross printed 46 sessions ago. Computed from daily closes.
均线状态
- 相对20日均线-1.2%
- 相对50日均线-4.6%
- 相对200日均线-16.8%
- 52周区间低于52周高点30.6% · 高于52周低点3%
- 连续走势连续2个交易日上涨
- 均线交叉死叉(46个交易日前)
- 50日均线交叉股价向下穿越50日均线(66个交易日前)
- 随机指标%K 34 · %D 13.2(金叉)
相关页面: TUB.BR图表与概览 · 质量与财务体检 · 信号看板
FAQ · from the current data · as of 2026-10-12
Quick answers
TUB.BR当前的Closelook信号是什么?
Downtrend stack — Trades -4.6% vs the 50-day and -16.8% vs the 200-day average, 30.6% below the 52-week high and +3% off the 52-week low; a death cross printed 46 sessions ago. Computed from daily closes.(截至2026-10-12;信号看板每个交易日晚间对全部覆盖范围重新计算。研究日记读数,不构成投资建议。)
TUB.BR目前是否位于50日和200日均线上方?
截至2026-10-12,Tubize-Fin位于50日均线下方(-4.6%),200日均线下方(-16.8%);距20日均线-1.2%。
TUB.BR距52周高点有多远?
截至2026-10-12,低于52周高点30.6%,高于52周低点3%。
Related in the Closelooknet universe
then Biotechnology. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.
- HALO Halozyme Therapeutics Incindustry
- ARGX.BR Argen-Xindustry
- ONC BeiGene, Ltd.industry
- ARGX argenx NV ADRindustry
- KRYS Krystal Biotech Incindustry
- PTGX Protagonist Therapeutics Incindustry
- MRNA Moderna Incindustry
- DNA Ginkgo Bioworks Holdingsindustry
- ONT.L Oxford Nanopore Technologies Ltdindustry
- CAI Caris Life Sciences, Inc. Common Stockindustry
- RXRX Recursion Pharmaceuticals Incindustry
- EXEL Exelixis Incindustry
- TWST Twist Bioscience Corpindustry
- TECH Bio-Techne Corpindustry
- MRVI Maravai Lifesciences Holdings Incindustry
- RPRX Royalty Pharma Plcindustry
- BION.SW BB Biotech AGindustry
- INCY Incyte Corporationindustry
- JAZZ Jazz Pharmaceuticals PLCindustry
- NTLA Intellia Therapeutics Incindustry